FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113238466> ?p ?o ?g. }

• W3113238466 abstract "Abstract Background When and how to communicate effectively the results of genetic and biomarker based prediction, detection, and quantification of the brain substrates of dementia involve important ethical and legal issues critical for precision medicine. The urgency of the issue has increased as People Living with Dementia (PLwD) and with Risk for Dementia (PwRD) can access direct to consumer genetic testing, amyloid targeting drugs, and clinical amyloid PET scans. To address the need for effective dissemination and consultation, an advisory group was convened that welcomes all interested members. Method Members attend two meetings monthly via phone/computer/WebEx. One meeting is a targeted working group that focuses on the following: 1. Symptomatic (PLwD), 2. Asymptomatic (PwRD), 3. Research, 4. Ethics/Healthcare Law, 5. Trainee/Mentorship. These discussion groups hear from and present to stakeholders (PLwD/PwRD/caregivers, professional organizations, companies) to solicit feedback on the efficacy of their efforts. Members also attend a monthly “all hands” meeting where they receive updates from other groups and hear presentations on emerging research and resources. Result The advisory group is composed of 104 members who represent advocacy/stakeholders (21%, e.g. professional organization representatives, (PLwD/PwRD/caregivers, FDA), academia (78%, e.g. university, funders, foundations), and healthcare law (1%). Professions include geneticists, genetic counsellors, researchers, clinicians, ethicists, and lawyers. Motivations for joining include improving communication in research and clinical contexts, mitigating potential negative impacts (e.g.emotional distress or discrimination), and protecting rights to know. Topics have included DTC genomics, the impact of APOE disclosure, genetics and personalized medicine, ecological momentary assessment of response to disclosure, and ethical issues in national and international research registries (EPAD). Activities included a survey on disclosure practices in NIA funded ADCs and collaborations with ADEAR. Stakeholders varied in concerns ranging from a need to protect patients from disclosure to a need to protect the right of access. Conclusion Membership is increasing and is engaging diverse specialties and stakeholders who provide education and consultation around communication and use of genetic and biomarkers related to dementia. The group structure and inclusion of members from multiple organizations supports open and free collaboration. Future efforts will be developing structured education for stakeholders and publications." @default.
• W3113238466 created "2020-12-21" @default.
• W3113238466 creator A5000166407 @default.
• W3113238466 creator A5000626788 @default.
• W3113238466 creator A5001385550 @default.
• W3113238466 creator A5003873348 @default.
• W3113238466 creator A5004111671 @default.
• W3113238466 creator A5004387064 @default.
• W3113238466 creator A5006035931 @default.
• W3113238466 creator A5006645872 @default.
• W3113238466 creator A5011763234 @default.
• W3113238466 creator A5012342239 @default.
• W3113238466 creator A5012517697 @default.
• W3113238466 creator A5012890801 @default.
• W3113238466 creator A5013267732 @default.
• W3113238466 creator A5016205359 @default.
• W3113238466 creator A5020154795 @default.
• W3113238466 creator A5020416642 @default.
• W3113238466 creator A5022540553 @default.
• W3113238466 creator A5026257338 @default.
• W3113238466 creator A5030471563 @default.
• W3113238466 creator A5033086650 @default.
• W3113238466 creator A5033701996 @default.
• W3113238466 creator A5037143937 @default.
• W3113238466 creator A5038370606 @default.
• W3113238466 creator A5041531862 @default.
• W3113238466 creator A5045489502 @default.
• W3113238466 creator A5048002438 @default.
• W3113238466 creator A5048572359 @default.
• W3113238466 creator A5052759048 @default.
• W3113238466 creator A5054047738 @default.
• W3113238466 creator A5054057100 @default.
• W3113238466 creator A5055535949 @default.
• W3113238466 creator A5056213437 @default.
• W3113238466 creator A5057936622 @default.
• W3113238466 creator A5059469170 @default.
• W3113238466 creator A5062773469 @default.
• W3113238466 creator A5069870722 @default.
• W3113238466 creator A5073489682 @default.
• W3113238466 creator A5073782710 @default.
• W3113238466 creator A5077687204 @default.
• W3113238466 creator A5079745650 @default.
• W3113238466 creator A5080612573 @default.
• W3113238466 creator A5083700495 @default.
• W3113238466 creator A5085866198 @default.
• W3113238466 creator A5086664554 @default.
• W3113238466 date "2020-12-01" @default.
• W3113238466 modified "2023-10-01" @default.
• W3113238466 title "The formation of the advisory group on risk evaluation education for dementia" @default.
• W3113238466 doi "https://doi.org/10.1002/alz.045562" @default.
• W3113238466 hasPublicationYear "2020" @default.
• W3113238466 type Work @default.
• W3113238466 sameAs 3113238466 @default.
• W3113238466 citedByCount "1" @default.
• W3113238466 countsByYear W31132384662021 @default.
• W3113238466 crossrefType "journal-article" @default.
• W3113238466 hasAuthorship W3113238466A5000166407 @default.
• W3113238466 hasAuthorship W3113238466A5000626788 @default.
• W3113238466 hasAuthorship W3113238466A5001385550 @default.
• W3113238466 hasAuthorship W3113238466A5003873348 @default.
• W3113238466 hasAuthorship W3113238466A5004111671 @default.
• W3113238466 hasAuthorship W3113238466A5004387064 @default.
• W3113238466 hasAuthorship W3113238466A5006035931 @default.
• W3113238466 hasAuthorship W3113238466A5006645872 @default.
• W3113238466 hasAuthorship W3113238466A5011763234 @default.
• W3113238466 hasAuthorship W3113238466A5012342239 @default.
• W3113238466 hasAuthorship W3113238466A5012517697 @default.
• W3113238466 hasAuthorship W3113238466A5012890801 @default.
• W3113238466 hasAuthorship W3113238466A5013267732 @default.
• W3113238466 hasAuthorship W3113238466A5016205359 @default.
• W3113238466 hasAuthorship W3113238466A5020154795 @default.
• W3113238466 hasAuthorship W3113238466A5020416642 @default.
• W3113238466 hasAuthorship W3113238466A5022540553 @default.
• W3113238466 hasAuthorship W3113238466A5026257338 @default.
• W3113238466 hasAuthorship W3113238466A5030471563 @default.
• W3113238466 hasAuthorship W3113238466A5033086650 @default.
• W3113238466 hasAuthorship W3113238466A5033701996 @default.
• W3113238466 hasAuthorship W3113238466A5037143937 @default.
• W3113238466 hasAuthorship W3113238466A5038370606 @default.
• W3113238466 hasAuthorship W3113238466A5041531862 @default.
• W3113238466 hasAuthorship W3113238466A5045489502 @default.
• W3113238466 hasAuthorship W3113238466A5048002438 @default.
• W3113238466 hasAuthorship W3113238466A5048572359 @default.
• W3113238466 hasAuthorship W3113238466A5052759048 @default.
• W3113238466 hasAuthorship W3113238466A5054047738 @default.
• W3113238466 hasAuthorship W3113238466A5054057100 @default.
• W3113238466 hasAuthorship W3113238466A5055535949 @default.
• W3113238466 hasAuthorship W3113238466A5056213437 @default.
• W3113238466 hasAuthorship W3113238466A5057936622 @default.
• W3113238466 hasAuthorship W3113238466A5059469170 @default.
• W3113238466 hasAuthorship W3113238466A5062773469 @default.
• W3113238466 hasAuthorship W3113238466A5069870722 @default.
• W3113238466 hasAuthorship W3113238466A5073489682 @default.
• W3113238466 hasAuthorship W3113238466A5073782710 @default.
• W3113238466 hasAuthorship W3113238466A5077687204 @default.
• W3113238466 hasAuthorship W3113238466A5079745650 @default.
• W3113238466 hasAuthorship W3113238466A5080612573 @default.
• W3113238466 hasAuthorship W3113238466A5083700495 @default.
• W3113238466 hasAuthorship W3113238466A5085866198 @default.
• W3113238466 hasAuthorship W3113238466A5086664554 @default.

• next